Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review

Background: Immune checkpoint inhibitors (ICI) have represented a revolution in the treatment of non-small-cell lung cancer (NSCLC). To improve these results, combined approaches are being tested. The addition of stereotactic ablative radiotherapy (SABR) to ICI seems promising. A systematic review w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chicas-Sett, Rodolfo, Morales-Orue, Ignacio, Castilla-Martinez, Juan, Zafra-Martin, Juan, Kannemann, Andrea, Blanco, Jesus, Lloret, Marta, Lara, Pedro C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540197/
https://www.ncbi.nlm.nih.gov/pubmed/31052488
http://dx.doi.org/10.3390/ijms20092173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540197/
https://www.ncbi.nlm.nih.gov/pubmed/31052488
http://dx.doi.org/10.3390/ijms20092173

Ejemplares similares